QA: Lixte Biotechnology Holdings INC in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001335105_2025_Lixte_Biotechnology_Holdings_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001335105, Lixte Biotechnology Holdings INC

  xvar xval
0 AssetsCurrent 0
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 1,145,503
4 LiabilitiesCurrent 318,284
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,499,883
9 ResearchAndDevelopmentExpense 704,552
10 remainder_Expenses 492,120
11 remainder_Revenues 0
12 remainder_NetIncome 9,054
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 1,145,503
1 Liabilities 318,284
2 Expenses 3,696,555
3 Revenues 0
4 StockholdersEquity 827,219
5 NetIncome -3,687,501
6 ComprehensiveNetIncome -3,687,501
7 BaseVar 2,584,698
8 EconomicCapitalRatiobeforeLimitedLiability -2.57
9 EconomicCapitalRatio 0.830

Edgar->Model Mapping

Feature Distribution

Change over Time